Hematology/Oncology News

Chimeric antigen receptor T-cell therapy can reduce tumor burden and improve neurologic function for patients with certain brain and spinal cord cancers, a first-in-human clinical trial showed.

One-third of childhood cancer survivors reported high levels of fear of cancer recurrence even decades after treatment, according to results of a cross-sectional analysis.

Significant barriers to divorce during pregnancy and reproductive health care led to serious health risks among pregnant or recently pregnant women in the U.S. between 2018 and 2021, according to results of a cross-sectional study.

Cancer diagnoses fell significantly below expectations in 2020 due to the COVID-19 pandemic but recovered to projected levels the following year, according to results of a cross-sectional study.

Researchers developed a highly sensitive, analytic, quantitative immunofluorescence assay that may enable more patients with lung cancer to benefit from an approved targeted therapy.

The addition of cadonilimab to first-line chemotherapy improved outcomes among certain women with cervical cancer.

The addition of lorazepam to haloperidol reduced symptoms of agitated delirium among individuals with advanced cancers, according to study findings.

Single-fraction stereotactic body radiation therapy may be an effective treatment for individuals with central lung cancer, according to prospective study results presented at American Society for Radiation Oncology Annual Meeting.

Healio spoke with John Molina, MD, MEd, about research updates on the use of immunotherapy in leukemia from this year’s Society of Hematologic Oncology Annual Meeting.